Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus

Diabetes and Metabolism

Volumn 39, Issue 5, 2013, Pages 389-396

  Echouffo Tcheugui, J B ^a   Kengne, A P ^b,c,d  

^a EMORY UNIVERSITY   (United States)

^b GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cardiovascular disease; Diabetes mellitus; Performance; Risk models

Indexed keywords

ALGORITHM; CARDIOVASCULAR RISK; COMPARATIVE STUDY; DIABETES MELLITUS; DIABETIC PATIENT; HUMAN; MODEL; PERFORMANCE; REVIEW; RISK ASSESSMENT; SCORING SYSTEM;

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIABÈTE SUCRÉ; MALADE CARDIOVASCULAIRE; MODÈLES DE RISQUE; PERFORMANCE; RISK MODELS;

ALGORITHMS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MODELS, THEORETICAL; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS;

EID: 84885895899     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2013.07.002     Document Type: Review

References (45)

1. Booth G.L., Kapral M.K., Fung K., Tu J.V. Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 2006, 29:32-37.
2. Gu K., Cowie C.C., Harris M.I. Diabetes and decline in heart disease mortality in US adults. JAMA 1999, 281:1291-1297.
3. Fox C.S., Coady S., Sorlie P.D., D'Agostino R.B., Pencina M.J., Vasan R.S., et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 2007, 115:1544-1550.
4. Fox C.S., Coady S., Sorlie P.D., Levy D., Meigs J.B., D'Agostino R.B., et al. Trends in cardiovascular complications of diabetes. JAMA 2004, 292:2495-2499.
5. Gu K., Cowie C.C., Harris M.I. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care 1998, 21:1138-1145.
6. Centers for Disease Control Prevention National Diabetes Fact Sheet: National estimates and general information on diabetes and prediabetes in the United States 2010.
7. Bulugahapitiya U., Siyambalapitiya S., Sithole J., Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med 2009, 26:142-148.
8. Gonzalez-Clemente J.M., Palma S., Arroyo J., Vilardell C., Caixas A., Gimenez-Palop O., et al. [Is diabetes mellitus a coronary heart disease equivalent? Results of a meta-analysis of prospective studies]. Rev Esp Cardiol 2007, 60:1167-1176.
9. Howard B.V., Best L.G., Galloway J.M., Howard W.J., Jones K., Lee E.T., et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 2006, 29:391-397.
10. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234.
11. Colhoun H.M., Betteridge D.J., Durrington P.N., Hitman G.A., Neil H.A., Livingstone S.J., et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004, 364:685-696.
12. Collins R., Armitage J., Parish S., Sleigh P., Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003, 361:2005-2016.
13. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348:383-393.
14. Gaede P., Lund-Andersen H., Parving H.H., Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591.
15. van Dieren S., Beulens J.W., Kengne A.P., Peelen L.M., Rutten G.E., Woodward M., et al. Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review. Heart 2012, 98:360-369.
16. Kengne A.P., Patel A., Colagiuri S., Heller S., Hamet P., Marre M., et al. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. Diabetologia 2010, 53:821-831.
17. Stevens R.J., Kothari V., Adler A.I., Stratton I.M. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 2001, 101:671-679.
18. Kothari V., Stevens R.J., Adler A.I., Stratton I.M., Manley S.E., Neil H.A., et al. UKPDS 60 risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 2002, 33:1776-1781.
19. Kengne A.P., Patel A., Marre M., Travert F., Lievre M., Zoungas S., et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehab 2011, 18:393-398.
20. Elley C.R., Robinson E., Kenealy T., Bramley D., Drury P.L. Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: the new zealand diabetes cohort study. Diabetes Care 2010, 33:1347-1352.
21. Anderson K.M., Wilson P.W., Odell P.M., Kannel W.B. An updated coronary risk profile. A statement for health professionals. Circulation 1991, 83:356-362.
22. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
23. D'Agostino R.B., Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
24. Robinson T., Elley C.R., Wells S., Robinson E., Kenealy T., Pylypchuk R., et al. New Zealand Diabetes Cohort Study cardiovascular risk score for people with Type 2 diabetes: validation in the PREDICT cohort. J Prim Health Care 2012, 4:181-188.
25. Assmann G., Cullen P., Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002, 105:310-315.
26. Hingorani A.D., Vallance P. A simple computer program for guiding management of cardiovascular risk factors and prescribing. BMJ 1999, 318:101-105.
27. Conroy R.M., Pyorala K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987-1003.
28. Joint British recommendations on prevention of coronary heart disease in clinical practice, British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association Heart 1998, 80(Suppl.2):S1-S29.
29. Stephens J.W., Ambler G., Vallance P., Betteridge D.J., Humphries S.E., Hurel S.J. Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory?. Eur J Cardiovasc Prev Rehab 2004, 11:521-528.
30. Davis W.A., Colagiuri S., Davis T.M. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study. Med J Aust 2009, 190:180-184.
31. Simmons R.K., Coleman R.L., Price H.C., Holman R.R., Khaw K.T., Wareham N.J., et al. Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC-Norfolk Cohort. Diabetes Care 2009, 32:708-713.
32. Pellegrini E., Maurantonio M., Giannico I.M., Simonini M.S., Ganazzi D., Carulli L., et al. Risk for cardiovascular events in an Italian population of patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 2012, 21:885-892.
33. van der Heijden A.A., Ortegon M.M., Niessen L.W., Nijpels G., Dekker J.M. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study. Diabetes Care 2009, 32:2094-2098.
34. Guzder R.N., Gatling W., Mullee M.A., Mehta R.L., Byrne C.D. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study. Diabet Med 2005, 22:554-562.
35. Selvin E., Marinopoulos S., Berkenblit G., Rami T., Brancati F.L., Powe N.R., et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004, 141:421-431.
36. Lu S.E., Beckles G.L., Crosson J., Bilik D., Karter A.J., Gerzoff R.B., et al. Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the translating research into action for diabetes (triad) study. BMC Endocr Disord 2012, 12:12.
37. Protopsaltis I.D., Konstantinopoulos P.A., Kamaratos A.V., Melidonis A.I. Comparative study of prognostic value for coronary disease risk between the U.K.prospective diabetes study and Framingham models. Diabetes Care 2004, 27:277-278.
38. Chamnan P., Simmons R.K., Sharp S.J., Griffin S.J., Wareham N.J. Cardiovascular risk assessment scores for people with diabetes: a systematic review. Diabetologia 2009, 52:2001-2014.
39. Coutinho M., Gerstein H.C., Wang Y., Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999, 22:233-240.
40. Miettinen H., Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care 1996, 19:1445-1448.
41. Targher G., Bertolini L., Tessari R., Zenari L., Arcaro G. Retinopathy predicts future cardiovascular events among type 2 diabetic patients: the Valpolicella Heart Diabetes Study. Diabetes Care 2006, 29:1178.
42. van Hecke M.V., Dekker J.M., Stehouwer C.D., Polak B.C., Fuller J.H., Sjolie A.K., et al. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care 2005, 28:1383-1389.
43. Juutilainen A., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 2007, 30:292-299.
44. Moons K., Kengne A.P., Woodward M., Royston P., Vergouwe Y., Altman D., et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 2012, 98(9):683-690.
45. Moons K., Kengne A.P., Grobbee D.E., Royston P., Vergouwe Y., Altman D., et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart 2012, 98(9):691-698.